Lumos Pharma’s Tender Offer and Merger with Double Point Ventures

Leila Ahmed
Tagged:

Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures.Lumos Pharma (NASDAQ:LUMO), a clinical stage…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here